Hypaque Injection and Ustekinumab Subcutaneous
Determining the interaction of Hypaque Injection and Ustekinumab Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: diatrizoate
Brand name: Cystografin, Cystografin-Dilute, Gastrografin, MD-76 R, MD-Gastroview
Synonyms: Diatrizoate Meglumine
Generic Name: ustekinumab
Brand name: Stelara, Stelara PFS
Synonyms: Ustekinumab (Subcutaneous)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Hypaque Injection-Ustekinumab Subcutaneous Injection
- Hypaque Injection-Ustell
- Hypaque Injection-UTA
- Hypaque Injection-UTA Capsules
- Hypaque Injection-UTAC tablets
- Hypaque Injection-UTI Relief
- Ustekinumab Subcutaneous-Hypaque Meglumine
- Ustekinumab Subcutaneous-Hypaque-76
- Ustekinumab Subcutaneous-Hypaque-Cysto
- Ustekinumab Subcutaneous-Hyper-Sal inhalation
- Ustekinumab Subcutaneous-Hyperhep B
- Ustekinumab Subcutaneous-HyperHEP B S/D